What Do We Really Know About the Treatment of Delirium with Antipsychotics? Ten Key Issues for Delirium Pharmacotherapy
- 1 December 2013
- journal article
- review article
- Published by Elsevier BV in American Journal of Geriatric Psychiatry
- Vol. 21 (12), 1223-1238
- https://doi.org/10.1016/j.jagp.2012.09.008
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Early Treatment with Risperidone for Subsyndromal Delirium after On-pump Cardiac Surgery in the ElderlyAnesthesiology, 2012
- Features of subsyndromal and persistent deliriumThe British Journal of Psychiatry, 2012
- Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled studyCritical Care, 2011
- Risperidone versus olanzapine for the treatment of deliriumHuman Psychopharmacology: Clinical and Experimental, 2010
- A national survey of the management of delirium in UK intensive care unitsQJM: An International Journal of Medicine, 2010
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Implementation of a delirium assessment tool in the ICU can influence haloperidol useCritical Care, 2009
- Serum anticholinergic activity and cerebral cholinergic dysfunction: An EEG study in frail elderly with and without deliriumBMC Neuroscience, 2008
- Abnormal neurotransmitter metabolite levels in Alzheimer patients with a deliriumInternational Journal of Geriatric Psychiatry, 2006
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996